TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7126629
log Bayes Factor = 9.4176
Chromosome 11   position 2,228,952  (GRCh37) Explore rs7126629 on Ensembl!
Variant rs7126629 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
C61 Malignant neoplasm of prostate
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.999 0.001 0.000
E10.3 With ophthalmic complications
0.996 0.004 0.000
E10.9 Without complications
0.994 0.006 0.000
E10.1 With ketoacidosis
0.987 0.013 0.000
E10.4 With neurological complications
0.963 0.037 0.000
E10.2 With renal complications
0.943 0.057 0.000
E10.5 With peripheral circulatory complications
0.896 0.104 0.000
E10.8 With unspecified complications
0.759 0.241 0.000
E10.0 With coma
0.756 0.244 0.000
E10.7 With multiple complications
0.735 0.265 0.000
E10.6 With other specified complications
0.674 0.326 0.000
C60-C63 Malignant neoplasms of male genital organs
0.000 0.724 0.276
C63 Malignant neoplasm of other and unspecified male genital organs
0.000 0.806 0.194
E10-E14 Diabetes mellitus
0.188 0.812 0.000
C62 Malignant neoplasm of testis
0.000 0.825 0.175
C60 Malignant neoplasm of penis
0.000 0.832 0.167
E14 Unspecified diabetes mellitus
0.140 0.860 0.000
C63.9 Male genital organ, unspecified
0.000 0.861 0.139
C63.8 Overlapping lesion of male genital organs
0.000 0.861 0.139
C63.7 Other specified male genital organs
0.000 0.861 0.139
C63.1 Spermatic cord
0.000 0.861 0.139
C63.0 Epididymis
0.000 0.861 0.139
C62.1 Descended testis
0.000 0.863 0.137
C63.2 Scrotum
0.000 0.865 0.135
E12 Malnutrition-related diabetes mellitus
0.135 0.865 0.000
E14.3 With ophthalmic complications
0.132 0.868 0.000
C60.1 Glans penis
0.000 0.874 0.126
C62.0 Undescended testis
0.000 0.874 0.125
C60.8 Overlapping lesion of penis
0.000 0.880 0.120
C60.2 Body of penis
0.000 0.880 0.120
C60.0 Prepuce
0.000 0.891 0.108
E14.2 Withrenal complications
0.106 0.894 0.000
E14.1 With ketoacidosis
0.105 0.895 0.000
E14.6 With other specified complications
0.102 0.898 0.000
E13 Other specified diabetes mellitus
0.102 0.898 0.000
E14.5 With peripheral circulatory complications
0.101 0.899 0.000
E14.7 With multiple complications
0.101 0.899 0.000
E14.0 With coma
0.098 0.902 0.000
C60.9 Penis, unspecified
0.000 0.902 0.097
E12.9 Without complications
0.097 0.903 0.000
E12.8 With unspecified complications
0.097 0.903 0.000
E12.7 With multiple complications
0.097 0.903 0.000
E12.6 With other specified complications
0.097 0.903 0.000
E12.5 With peripheral circulatory complications
0.097 0.903 0.000
E12.4 With neurological complications
0.097 0.903 0.000
E12.3 With ophthalmic complications
0.097 0.903 0.000
E12.2 With renal complications
0.097 0.903 0.000
E12.1 With ketoacidosis
0.097 0.903 0.000
E12.0 With coma
0.097 0.903 0.000
E14.8 With unspecified complications
0.094 0.906 0.000
E14.4 With neurological complications
0.087 0.913 0.000
C62.9 Testis, unspecified
0.000 0.919 0.081
E13.8 With unspecified complications
0.073 0.926 0.000
E13.7 With multiple complications
0.073 0.926 0.000
E13.6 With other specified complications
0.073 0.926 0.000
E13.5 With peripheral circulatory complications
0.073 0.926 0.000
E13.4 With neurological complications
0.073 0.926 0.000
E13.2 With renal complications
0.073 0.926 0.000
E13.1 With ketoacidosis
0.073 0.926 0.000
E13.0 With coma
0.073 0.926 0.000
E13.3 With ophthalmic complications
0.061 0.938 0.000
E13.9 Without complications
0.059 0.941 0.000
E11 Non-insulin-dependent diabetes mellitus
0.047 0.953 0.000
E11.0 With coma
0.039 0.961 0.000
E11.2 With renal complications
0.037 0.962 0.000
E11.8 With unspecified complications
0.037 0.963 0.000
E11.5 With peripheral circulatory complications
0.036 0.964 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.036 0.964 0.000
E11.7 With multiple complications
0.035 0.965 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.035 0.965 0.000
E16 Other disorders of pancreatic internal secretion
0.034 0.966 0.000
E16.2 Hypoglycaemia, unspecified
0.033 0.967 0.000
E11.6 With other specified complications
0.032 0.968 0.000
E20-E35 Disorders of other endocrine glands
0.031 0.969 0.000
E16.1 Other hypoglycaemia
0.029 0.971 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.028 0.972 0.000
E21.3 Hyperparathyroidism, unspecified
0.027 0.973 0.000
E11.4 With neurological complications
0.027 0.973 0.000
E22 Hyperfunction of pituitary gland
0.027 0.973 0.000
E24 Cushing's syndrome
0.026 0.974 0.000
G62.9 Polyneuropathy, unspecified
0.026 0.974 0.000
E34 Other endocrine disorders
0.026 0.974 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.025 0.974 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.025 0.975 0.000
E15 Nondiabetic hypoglycaemic coma
0.025 0.975 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.025 0.975 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.025 0.975 0.000
E16.4 Abnormal secretion of gastrin
0.025 0.975 0.000
E16.3 Increased secretion of glucagon
0.025 0.975 0.000
E20 Hypoparathyroidism
0.024 0.976 0.000
E40-E46 Malnutrition
0.024 0.976 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.024 0.976 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.023 0.977 0.000
E34.0 Carcinoid syndrome
0.022 0.978 0.000
E32 Diseases of thymus
0.022 0.978 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.022 0.978 0.000
E30 Disorders of puberty, not elsewhere classified
0.022 0.978 0.000
E29 Testicular dysfunction
0.022 0.978 0.000
E11.1 With ketoacidosis
0.022 0.978 0.000
G62 Other polyneuropathies
0.022 0.978 0.000
E31 Polyglandular dysfunction
0.022 0.978 0.000
E26 Hyperaldosteronism
0.022 0.978 0.000
E21.2 Other hyperparathyroidism
0.021 0.979 0.000
E24.8 Other Cushing's syndrome
0.021 0.979 0.000
E24.9 Cushing's syndrome, unspecified
0.021 0.979 0.000
E25 Adrenogenital disorders
0.021 0.979 0.000
E34.8 Other specified endocrine disorders
0.021 0.979 0.000
E22.0 Acromegaly and pituitary gigantism
0.020 0.979 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.020 0.980 0.000
E11.3 With ophthalmic complications
0.020 0.980 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.020 0.980 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.020 0.980 0.000
E00-E07 Disorders of thyroid gland
0.020 0.980 0.000
E24.0 Pituitary-dependent Cushing's disease
0.020 0.980 0.000
E22.8 Other hyperfunction of pituitary gland
0.019 0.981 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.019 0.981 0.000
E34.9 Endocrine disorder, unspecified
0.019 0.981 0.000
E20.9 Hypoparathyroidism, unspecified
0.019 0.981 0.000
Z50.1 Other physical therapy
0.000 0.981 0.019
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.019 0.981 0.000
E24.3 Ectopic ACTH syndrome
0.019 0.981 0.000
E24.1 Nelson's syndrome
0.019 0.981 0.000
G62.0 Drug-induced polyneuropathy
0.019 0.981 0.000
E34.5 Androgen resistance syndrome
0.019 0.981 0.000
E34.4 Constitutional tall stature
0.019 0.981 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.019 0.981 0.000
E34.1 Other hypersecretion of intestinal hormones
0.019 0.981 0.000
E24.2 Drug-induced Cushing's syndrome
0.019 0.981 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.019 0.981 0.000
E20.1 Pseudohypoparathyroidism
0.018 0.982 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.018 0.982 0.000
G62.8 Other specified polyneuropathies
0.018 0.982 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.018 0.982 0.000
E20.8 Other hypoparathyroidism
0.018 0.982 0.000
E20.0 Idiopathic hypoparathyroidism
0.018 0.982 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.017 0.982 0.000
E45 Retarded development following protein-energy malnutrition
0.017 0.982 0.000
E43 Unspecified severe protein-energy malnutrition
0.017 0.982 0.000
E42 Marasmic kwashiorkor
0.017 0.982 0.000
E41 Nutritional marasmus
0.017 0.982 0.000
E40 Kwashiorkor
0.017 0.982 0.000
E21.4 Other specified disorders of parathyroid gland
0.017 0.982 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.017 0.983 0.000
E34.3 Short stature, not elsewhere classified
0.017 0.983 0.000
T40.4 Other synthetic narcotics
0.017 0.983 0.000
T40.2 Other opioids
0.017 0.983 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.017 0.983 0.000
T36 Poisoning by systemic antibiotics
0.017 0.983 0.000
T40.5 Cocaine
0.017 0.983 0.000
E06 Thyroiditis
0.017 0.983 0.000
F10.2 Dependence syndrome
0.017 0.983 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.017 0.983 0.000
E29.9 Testicular dysfunction, unspecified
0.016 0.983 0.000
E28 Ovarian dysfunction
0.016 0.984 0.000
E32.8 Other diseases of thymus
0.016 0.984 0.000
E32.9 Disease of thymus, unspecified
0.016 0.984 0.000
E32.1 Abscess of thymus
0.016 0.984 0.000
E32.0 Persistent hyperplasia of thymus
0.016 0.984 0.000
E30.9 Disorder of puberty, unspecified
0.016 0.984 0.000
E30.8 Other disorders of puberty
0.016 0.984 0.000
E30.1 Precocious puberty
0.016 0.984 0.000
E30.0 Delayed puberty
0.016 0.984 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.016 0.984 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.016 0.984 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.016 0.984 0.000
E29.8 Other testicular dysfunction
0.016 0.984 0.000
E29.0 Testicular hyperfunction
0.016 0.984 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.016 0.984 0.000
G62.1 Alcoholic polyneuropathy
0.016 0.984 0.000
T50.4 Drugs affecting uric acid metabolism
0.016 0.984 0.000
E46 Unspecified protein-energy malnutrition
0.016 0.984 0.000
G62.2 Polyneuropathy due to other toxic agents
0.016 0.984 0.000
E31.9 Polyglandular dysfunction, unspecified
0.016 0.984 0.000
E31.8 Other polyglandular dysfunction
0.016 0.984 0.000
E31.1 Polyglandular hyperfunction
0.016 0.984 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.016 0.984 0.000
E26.0 Primary hyperaldosteronism
0.016 0.984 0.000
E26.8 Other hyperaldosteronism
0.016 0.984 0.000
E26.1 Secondary hyperaldosteronism
0.016 0.984 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.016 0.984 0.000
T40.1 Heroin
0.016 0.984 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.016 0.984 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.016 0.984 0.000
E29.1 Testicular hypofunction
0.016 0.984 0.000
E31.0 Autoimmune polyglandular failure
0.015 0.984 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.015 0.985 0.000
E25.9 Adrenogenital disorder, unspecified
0.015 0.985 0.000
E25.8 Other adrenogenital disorders
0.015 0.985 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.015 0.985 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.015 0.985 0.000
T46.1 Calcium-channel blockers
0.015 0.985 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.015 0.985 0.000
E26.9 Hyperaldosteronism, unspecified
0.015 0.985 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.015 0.985 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.015 0.985 0.000
E14.9 Without complications
0.015 0.985 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.015 0.985 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.014 0.985 0.000
T40.8 Lysergide [LSD]
0.014 0.985 0.000
T40.7 Cannabis (derivatives)
0.014 0.985 0.000
T40.0 Opium
0.014 0.985 0.000
T40.6 Other and unspecified narcotics
0.015 0.985 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.014 0.985 0.000
E00 Congenital iodine-deficiency syndrome
0.014 0.985 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.014 0.986 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.014 0.986 0.000
E06.9 Thyroiditis, unspecified
0.014 0.986 0.000
T40.3 Methadone
0.014 0.986 0.000
T50.7 Analeptics and opioid receptor antagonists
0.014 0.986 0.000
T50.5 Appetite depressants
0.014 0.986 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.014 0.986 0.000
T50.0 Mineralocorticoids and their antagonists
0.014 0.986 0.000
T36.0 Penicillins
0.014 0.986 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.014 0.986 0.000
S01.8 Open wound of other parts of head
0.014 0.986 0.000
T50.8 Diagnostic agents
0.014 0.986 0.000
T50.1 Loop [high-ceiling] diuretics
0.014 0.986 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.014 0.986 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.014 0.986 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.014 0.986 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.014 0.986 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.014 0.986 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.014 0.986 0.000
T44.0 Anticholinesterase agents
0.014 0.986 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.014 0.986 0.000
E05.8 Other thyrotoxicosis
0.013 0.986 0.000
T38.1 Thyroid hormones and substitutes
0.013 0.986 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.013 0.987 0.000
S01.2 Open wound of nose
0.013 0.987 0.000
E06.3 Autoimmune thyroiditis
0.013 0.987 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.013 0.987 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.013 0.987 0.000
T46.7 Peripheral vasodilators
0.013 0.987 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.013 0.987 0.000
T45.0 Antiallergic and antiemetic drugs
0.013 0.987 0.000
E50-E64 Other nutritional deficiencies
0.013 0.987 0.000
T36.8 Other systemic antibiotics
0.013 0.987 0.000
T36.3 Macrolides
0.013 0.987 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.013 0.987 0.000
T38.0 Glucocorticoids and synthetic analogues
0.013 0.987 0.000
E44.1 Mild protein-energy malnutrition
0.013 0.987 0.000
E44.0 Moderate protein-energy malnutrition
0.013 0.987 0.000
S01 Open wound of head
0.013 0.987 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.013 0.987 0.000
T38.5 Other oestrogens and progestogens
0.013 0.987 0.000
T38.9 Other and unspecified hormone antagonists
0.013 0.987 0.000
T38.7 Androgens and anabolic congeners
0.013 0.987 0.000
T38.4 Oral contraceptives
0.013 0.987 0.000
T38.2 Antithyroid drugs
0.013 0.987 0.000
G60 Hereditary and idiopathic neuropathy
0.013 0.987 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.012 0.987 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.013 0.987 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.012 0.987 0.000
E06.1 Subacute thyroiditis
0.012 0.988 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.012 0.988 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.012 0.988 0.000
T36.9 Systemic antibiotic, unspecified
0.012 0.988 0.000
T36.7 Antifungal antibiotics, systemically used
0.012 0.988 0.000
T36.6 Rifamycins
0.012 0.988 0.000
T36.5 Aminoglycosides
0.012 0.988 0.000
T36.2 Chloramphenicol group
0.012 0.988 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.012 0.988 0.000
E06.4 Drug-induced thyroiditis
0.012 0.988 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.012 0.988 0.000
E06.0 Acute thyroiditis
0.012 0.988 0.000
E23 Hypofunction and other disorders of pituitary gland
0.012 0.988 0.000
E05.5 Thyroid crisis or storm
0.012 0.988 0.000
E05.4 Thyrotoxicosis factitia
0.012 0.988 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.012 0.988 0.000
T47.0 Histamine H(2)-receptor antagonists
0.012 0.988 0.000
E28.9 Ovarian dysfunction, unspecified
0.012 0.988 0.000
E28.8 Other ovarian dysfunction
0.012 0.988 0.000
E28.1 Androgen excess
0.012 0.988 0.000
E28.0 Oestrogen excess
0.012 0.988 0.000
I78.1 Naevus, nonneoplastic
0.000 0.988 0.012
E21.0 Primary hyperparathyroidism
0.012 0.988 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.012 0.988 0.000
T45.2 Vitamins, not elsewhere classified
0.012 0.988 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.012 0.988 0.000
T45.4 Iron and its compounds
0.012 0.988 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.012 0.988 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.011 0.988 0.000
T45.8 Other primarily systemic and haematological agents
0.011 0.988 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.011 0.988 0.000
T45.6 Fibrinolysis-affecting drugs
0.011 0.988 0.000
T45.3 Enzymes, not elsewhere classified
0.011 0.988 0.000
E07 Other disorders of thyroid
0.012 0.988 0.000
T41.2 Other and unspecified general anaesthetics
0.011 0.988 0.000
G60.0 Hereditary motor and sensory neuropathy
0.012 0.988 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.011 0.988 0.000
T47.6 Antidiarrhoeal drugs
0.011 0.988 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.011 0.988 0.000
T37.5 Antiviral drugs
0.011 0.988 0.000
T37.4 Anthelminthics
0.011 0.988 0.000
T37.3 Other antiprotozoal drugs
0.011 0.988 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.011 0.988 0.000
T37.1 Antimycobacterial drugs
0.011 0.988 0.000
T37.0 Sulphonamides
0.011 0.988 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.011 0.988 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.011 0.988 0.000
D25.0 Submucous leiomyoma of uterus
0.000 0.989 0.011
G60.8 Other hereditary and idiopathic neuropathies
0.011 0.989 0.000
T36.4 Tetracyclines
0.011 0.989 0.000
E22.1 Hyperprolactinaemia
0.011 0.989 0.001
E06.5 Other chronic thyroiditis
0.011 0.989 0.000
E05.9 Thyrotoxicosis, unspecified
0.011 0.989 0.000
T49.9 Topical agent, unspecified
0.011 0.989 0.000
T49.8 Other topical agents
0.011 0.989 0.000
T49.7 Dental drugs, topically applied
0.011 0.989 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.011 0.989 0.000
T49.5 Ophthalmological drugs and preparations
0.011 0.989 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.011 0.989 0.000
T49.3 Emollients, demulcents and protectants
0.011 0.989 0.000
T49.2 Local astringents and local detergents
0.011 0.989 0.000
T49.1 Antipruritics
0.011 0.989 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.011 0.989 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.011 0.989 0.000
T47.7 Emetics
0.011 0.989 0.000
T47.5 Digestants
0.011 0.989 0.000
T47.3 Saline and osmotic laxatives
0.011 0.989 0.000
T41.5 Therapeutic gases
0.011 0.989 0.000
T41.4 Anaesthetic, unspecified
0.011 0.989 0.000
T41.3 Local anaesthetics
0.011 0.989 0.000
T41.1 Intravenous anaesthetics
0.011 0.989 0.000
T41.0 Inhaled anaesthetics
0.011 0.989 0.000
T39.0 Salicylates
0.011 0.989 0.000
S01.3 Open wound of ear
0.011 0.989 0.000
T47.2 Stimulant laxatives
0.011 0.989 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.011 0.989 0.000
E54 Ascorbic acid deficiency
0.011 0.989 0.000
S01.4 Open wound of cheek and temporomandibular area
0.011 0.989 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.011 0.989 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.011 0.989 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.011 0.989 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.011 0.989 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.011 0.989 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.011 0.989 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.011 0.989 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.011 0.989 0.000
S01.9 Open wound of head, part unspecified
0.011 0.989 0.000
E28.2 Polycystic ovarian syndrome
0.010 0.989 0.000
T47.4 Other laxatives
0.010 0.990 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.010 0.990 0.000
T39.4 Antirheumatics, not elsewhere classified
0.010 0.990 0.000
T39.2 Pyrazolone derivatives
0.010 0.990 0.000
G60.9 Hereditary and idiopathic neuropathy, unspecified
0.010 0.990 0.000
E65-E68 Obesity and other hyperalimentation
0.010 0.990 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.010 0.990 0.000
T48.4 Expectorants
0.010 0.990 0.000
T48.3 Antitussives
0.010 0.990 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.010 0.990 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.010 0.990 0.000
T48.0 Oxytocic drugs
0.010 0.990 0.000
F10.4 Withdrawal state with delirium
0.010 0.990 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.009 0.990 0.000
E50 Vitamin A deficiency
0.009 0.990 0.000
E60 Dietary zinc deficiency
0.009 0.990 0.000
E59 Dietary selenium deficiency
0.009 0.990 0.000
E52 Niacin deficiency [pellagra]
0.009 0.990 0.000
T45.5 Anticoagulants
0.009 0.990 0.000
E63 Other nutritional deficiencies
0.009 0.990 0.000
E56 Other vitamin deficiencies
0.009 0.990 0.000
T39.1 4-Aminophenol derivatives
0.009 0.991 0.000
E23.7 Disorder of pituitary gland, unspecified
0.009 0.991 0.000
F10.6 Amnesic syndrome
0.009 0.991 0.000
G60.3 Idiopathic progressive neuropathy
0.009 0.991 0.000
G60.2 Neuropathy in association with hereditary ataxia
0.009 0.991 0.000
G60.1 Refsum's disease
0.009 0.991 0.000
E58 Dietary calcium deficiency
0.009 0.991 0.000
F10.0 Acute intoxication
0.009 0.991 0.000
T43.9 Psychotropic drug, unspecified
0.009 0.991 0.000
S01.1 Open wound of eyelid and periocular area
0.009 0.991 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.009 0.991 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.009 0.991 0.000
E23.1 Drug-induced hypopituitarism
0.009 0.991 0.000
E04 Other non-toxic goitre
0.009 0.991 0.000
E51 Thiamine deficiency
0.009 0.991 0.000
T48.5 Anti-common-cold drugs
0.009 0.991 0.000
G63 Polyneuropathy in diseases classified elsewhere
0.009 0.991 0.000
E61 Deficiency of other nutrient elements
0.009 0.991 0.000
S01.7 Multiple open wounds of head
0.009 0.991 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.009 0.991 0.000
F10.5 Psychotic disorder
0.009 0.991 0.000
E23.6 Other disorders of pituitary gland
0.009 0.991 0.000
T43.6 Psychostimulants with abuse potential
0.009 0.991 0.000
T43.2 Other and unspecified antidepressants
0.009 0.991 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.009 0.991 0.000
G64 Other disorders of peripheral nervous system
0.009 0.991 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.008 0.991 0.000
F10.9 Unspecified mental and behavioural disorder
0.009 0.991 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.008 0.991 0.000
E07.1 Dyshormogenetic goitre
0.008 0.991 0.000
E07.0 Hypersecretion of calcitonin
0.008 0.991 0.000
S01.5 Open wound of lip and oral cavity
0.009 0.991 0.000
F10.8 Other mental and behavioural disorders
0.008 0.992 0.000
F10.1 Harmful use
0.008 0.992 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.008 0.992 0.000
E28.3 Primary ovarian failure
0.008 0.992 0.000
E07.8 Other specified disorders of thyroid
0.008 0.992 0.000
F10.7 Residual and late-onset psychotic disorder
0.008 0.992 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.008 0.992 0.000
E03 Other hypothyroidism
0.008 0.992 0.000
E67 Other hyperalimentation
0.007 0.993 0.000
E68 Sequelae of hyperalimentation
0.007 0.993 0.000
E04.9 Non-toxic goitre, unspecified
0.007 0.993 0.000
E50.9 Vitamin A deficiency, unspecified
0.007 0.993 0.000
E50.8 Other manifestations of vitamin A deficiency
0.007 0.993 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.007 0.993 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.007 0.993 0.000
E50.5 Vitamin A deficiency with night blindness
0.007 0.993 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.007 0.993 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.007 0.993 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.007 0.993 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.007 0.993 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.007 0.993 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.007 0.993 0.000
E64.8 Sequelae of other nutritional deficiencies
0.007 0.993 0.000
E64.3 Sequelae of rickets
0.007 0.993 0.000
E64.2 Sequelae of vitamin C deficiency
0.007 0.993 0.000
E64.1 Sequelae of vitamin A deficiency
0.007 0.993 0.000
E64.0 Sequelae of protein-energy malnutrition
0.007 0.993 0.000
E55 Vitamin D deficiency
0.007 0.993 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.007 0.993 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.007 0.993 0.000
E56.9 Vitamin deficiency, unspecified
0.007 0.993 0.000
E56.8 Deficiency of other vitamins
0.007 0.993 0.000
E56.0 Deficiency of vitamin E
0.007 0.993 0.000
E63.8 Other specified nutritional deficiencies
0.007 0.993 0.000
E63.1 Imbalance of constituents of food intake
0.007 0.993 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.007 0.993 0.000
E23.2 Diabetes insipidus
0.007 0.993 0.000
E63.9 Nutritional deficiency, unspecified
0.007 0.993 0.000
E56.1 Deficiency of vitamin K
0.007 0.993 0.000
E85 Amyloidosis
0.007 0.993 0.000
E04.8 Other specified non-toxic goitre
0.007 0.993 0.000
E51.9 Thiamine deficiency, unspecified
0.006 0.993 0.000
E51.8 Other manifestations of thiamine deficiency
0.006 0.993 0.000
E51.1 Beriberi
0.006 0.993 0.000
E04.0 Non-toxic diffuse goitre
0.007 0.993 0.000
G63.8 Polyneuropathy in other diseases classified elsewhere
0.007 0.993 0.000
G63.6 Polyneuropathy in other musculoskeletal disorders
0.007 0.993 0.000
G63.5 Polyneuropathy in systemic connective tissue disorders
0.007 0.993 0.000
G63.4 Polyneuropathy in nutritional deficiency
0.007 0.993 0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.007 0.993 0.000
G63.1 Polyneuropathy in neoplastic disease
0.007 0.993 0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.007 0.993 0.000
E61.9 Deficiency of nutrient element, unspecified
0.006 0.993 0.000
E61.8 Deficiency of other specified nutrient elements
0.006 0.993 0.000
E61.7 Deficiency of multiple nutrient elements
0.006 0.993 0.000
E61.6 Vanadium deficiency
0.006 0.993 0.000
E61.5 Molybdenum deficiency
0.006 0.993 0.000
E61.4 Chromium deficiency
0.006 0.993 0.000
E61.3 Manganese deficiency
0.006 0.993 0.000
E61.0 Copper deficiency
0.006 0.993 0.000
F11 Mental and behavioural disorders due to use of opioids
0.007 0.993 0.000
E61.2 Magnesium deficiency
0.006 0.993 0.000
E85.4 Organ-limited amyloidosis
0.007 0.993 0.000
G63.2 Diabetic polyneuropathy
0.006 0.994 0.000
K70.9 Alcoholic liver disease, unspecified
0.006 0.994 0.000
E27 Other disorders of adrenal gland
0.006 0.994 0.000
E85.3 Secondary systemic amyloidosis
0.006 0.994 0.000
E03.1 Congenital hypothyroidism without goitre
0.006 0.994 0.000
E07.9 Disorder of thyroid, unspecified
0.006 0.994 0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified
0.000 0.994 0.006
F10.3 Withdrawal state
0.006 0.994 0.000
E51.2 Wernicke's encephalopathy
0.006 0.994 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.006 0.994 0.000
Z50 Care involving use of rehabilitation procedures
0.000 0.994 0.006
E61.1 Iron deficiency
0.006 0.994 0.000
F11.1 Harmful use
0.006 0.994 0.000
Q21.1 Atrial septal defect
0.006 0.994 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.006 0.994 0.000
E85.8 Other amyloidosis
0.006 0.994 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.006 0.994 0.000
E70-E90 Metabolic disorders
0.006 0.994 0.000
F11.2 Dependence syndrome
0.006 0.994 0.000
E03.5 Myxoedema coma
0.006 0.994 0.000
E03.4 Atrophy of thyroid (acquired)
0.006 0.994 0.000
E03.3 Postinfectious hypothyroidism
0.006 0.994 0.000
Z50.5 Speech therapy
0.000 0.994 0.006
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.006 0.994 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.006 0.994 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.006 0.994 0.000
E88 Other metabolic disorders
0.006 0.994 0.000
E67.8 Other specified hyperalimentation
0.005 0.994 0.000
E67.3 Hypervitaminosis D
0.005 0.994 0.000
E67.2 Megavitamin-B6 syndrome
0.005 0.994 0.000
E67.1 Hypercarotenaemia
0.005 0.994 0.000
E67.0 Hypervitaminosis A
0.005 0.994 0.000
E55.0 Rickets, active
0.005 0.995 0.000
E85.9 Amyloidosis, unspecified
0.005 0.995 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.005 0.995 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.005 0.995 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.005 0.995 0.000
F12.1 Harmful use
0.005 0.995 0.000
E53 Deficiency of other B group vitamins
0.005 0.995 0.001
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.005 0.995 0.000
S06 Intracranial injury
0.005 0.995 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.005 0.995 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.